Clinical trial · Observational
Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus (HPV) Types in Women >= 15 Years of Age, in the Kingdom of Saudi Arabia
NCT01213459CI-TRIAL-00008527completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to determine the prevalence of human papillomavirus (HPV) and to assess the HPV type distribution among women \>= 15 years of age, attending routine gynaecological examination in the Kingdom of Saudi Arabia.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Infections, Papillomavirus | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cervical samples | Procedure | — | UNRESOLVED |
| Data collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Cohort A
- description
- Women ≥15 years of age attending out-patient departments for routine cervical screening in the Kingdom of Saudi Arabia.
- interventionNames
- Procedure: Cervical samples
- Other: Data collection
Primary outcomes (1)
- measure
- Prevalence of any human papillomavirus deoxyribo nucleic acid and of different types of human papillomavirus (including multiple infections) among women undergoing cervical screening.
- timeFrame
- At least 12 months from the date of subject enrolment
Secondary outcomes (3)
- measure
- Prevalence of any human papillomavirus deoxyribo nucleic acid and of different types of human papillomavirus (high risk and low risk) among women of different age strata undergoing cervical screening.
- timeFrame
- At least 12 months from the date of subject enrolment
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects/Subjects' parents or guardians, who the investigator believes that they can and will comply with the requirements of the protocol should be enrolled in the study, * Women \>=15 years of age attending a clinic for routine cervical screening, * Written informed consent obtained from the subject and/or subject's parent/guardian. Exclusion Criteria: * Referral for abnormal cervical sample at the current visit, * Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to be performed, * No cervical sample provided, * History of hysterectomy, * Known diagnosis of immunosuppression, or patient on immunosuppressives, * Pregnant female \>=25 years of age.
References
Publications (1)
- DERIVEDAlObaid A, Al-Badawi IA, Al-Kadri H, Gopala K, Kandeil W, Quint W, Al-Aker M, DeAntonio R. Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia. BMC Infect Dis. 2014 Dec 14;14:643. doi: 10.1186/s12879-014-0643-8. PMID 25496614